# Veru (VERU) — Overview

VERU · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/veru

## Price

Last close $2.44 on Oct 15, 2026. 52-week range $2.09 – $4.43.

## Company profile

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$7.0M |
| Net income growth (year over year) | 4.70% |
| Net margin | 0.00% |
| Return on equity | -62.25% |
| EPS (trailing twelve months) | −$0.58 |
| Book value per share | $1.66 |
| P/E (trailing twelve months) | — |
| Price to book | 1.5 |
| Debt to assets | 23.36% |
| Payout ratio | 248.25% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### How do I buy stock in Veru (VERU)?

VERU trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).